Gofen & Glossberg Cut Abbvie (ABBV) Stake By $611,328; Paragon Capital Management Has Cut Symantec (SYMC) Holding

Symantec Corporation (NASDAQ:SYMC) Logo

Paragon Capital Management Llc decreased Symantec Corp (SYMC) stake by 7.99% reported in 2017Q4 SEC filing. Paragon Capital Management Llc sold 33,507 shares as Symantec Corp (SYMC)’s stock declined 9.92%. The Paragon Capital Management Llc holds 385,978 shares with $10.83 million value, down from 419,485 last quarter. Symantec Corp now has $17.28 billion valuation. The stock decreased 2.93% or $0.84 during the last trading session, reaching $27.8. About 7.08M shares traded or 20.13% up from the average. Symantec Corporation (NASDAQ:SYMC) has declined 16.28% since April 28, 2017 and is downtrending. It has underperformed by 27.83% the S&P500.

Gofen & Glossberg Llc decreased Abbvie (ABBV) stake by 3.26% reported in 2017Q4 SEC filing. Gofen & Glossberg Llc sold 6,368 shares as Abbvie (ABBV)’s stock declined 6.31%. The Gofen & Glossberg Llc holds 188,730 shares with $18.25 million value, down from 195,098 last quarter. Abbvie now has $156.65 billion valuation. The stock increased 1.32% or $1.29 during the last trading session, reaching $98.73. About 6.12 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 28, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc has $15700 highest and $6 lowest target. $102.21’s average target is 3.52% above currents $98.73 stock price. Abbvie Inc had 90 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, December 5 by Leerink Swann. Goldman Sachs downgraded it to “Buy” rating and $68 target in Monday, March 7 report. The firm earned “Hold” rating on Tuesday, September 5 by Cowen & Co. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Friday, April 28 by BMO Capital Markets. On Thursday, April 5 the stock rating was maintained by Barclays Capital with “Equal-Weight”. As per Sunday, October 29, the company rating was maintained by SunTrust. The firm has “Buy” rating given on Wednesday, July 22 by SunTrust. The company was upgraded on Tuesday, August 11 by TheStreet. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Piper Jaffray on Tuesday, April 10. Deutsche Bank maintained it with “Hold” rating and $6 target in Monday, July 17 report.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It is negative, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Livingston Gru Asset Mgmt (Operating As Southport Cap Management), Tennessee-based fund reported 17,855 shares. Fuller & Thaler Asset Mngmt Incorporated owns 14,400 shares or 0.02% of their US portfolio. Smith Moore & Company has invested 0.79% in AbbVie Inc. (NYSE:ABBV). Janney Mngmt Ltd Llc owns 7,182 shares. Morgens Waterfall Vintiadis & stated it has 5,665 shares or 0.43% of all its holdings. Tekla Ltd Limited Liability Company accumulated 1.29% or 346,313 shares. Monroe Financial Bank Trust Mi owns 1,014 shares or 0.02% of their US portfolio. Moreover, Joel Isaacson Ltd has 0.07% invested in AbbVie Inc. (NYSE:ABBV). Asset One Ltd reported 0.57% of its portfolio in AbbVie Inc. (NYSE:ABBV). Cornerstone Inv Prtn Ltd Liability invested 0.07% in AbbVie Inc. (NYSE:ABBV). Alley Co Limited, a Illinois-based fund reported 41,086 shares. Barton Inv Mngmt accumulated 8,994 shares or 0.19% of the stock. Benjamin F Edwards & Co has invested 0.34% of its portfolio in AbbVie Inc. (NYSE:ABBV). Clarivest Asset Mngmt Ltd Liability Company holds 1.1% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 662,113 shares. 30,580 were accumulated by Daniel Devine And.

Since October 30, 2017, it had 0 buys, and 11 insider sales for $47.70 million activity. 83,574 shares valued at $9.57 million were sold by ALBAN CARLOS on Wednesday, February 28. SEVERINO MICHAEL sold $311,684 worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28. Shares for $157,458 were sold by SALEKI-GERHARDT AZITA on Wednesday, February 28. On Wednesday, February 28 the insider Michael Robert A. sold $512,853. RICHMOND TIMOTHY J. sold $2.15M worth of stock or 18,129 shares. Gosebruch Henry O had sold 18,300 shares worth $1.66M. CHASE WILLIAM J had sold 70,928 shares worth $8.31M on Wednesday, February 28.

Gofen & Glossberg Llc increased Nike Cl B (NYSE:NKE) stake by 4,979 shares to 346,153 valued at $21.65 million in 2017Q4. It also upped S&P Mid (MDY) stake by 2,484 shares and now owns 52,904 shares. Alphabet Cl C was raised too.

Among 32 analysts covering Symantec (NASDAQ:SYMC), 10 have Buy rating, 3 Sell and 19 Hold. Therefore 31% are positive. Symantec has $40 highest and $14 lowest target. $29.22’s average target is 5.11% above currents $27.8 stock price. Symantec had 92 analyst reports since August 11, 2015 according to SRatingsIntel. RBC Capital Markets downgraded Symantec Corporation (NASDAQ:SYMC) on Friday, May 19 to “Sector Perform” rating. The firm has “Buy” rating given on Thursday, August 3 by Oppenheimer. As per Monday, January 30, the company rating was maintained by Citigroup. Citigroup maintained the shares of SYMC in report on Monday, August 22 with “Buy” rating. The stock has “Hold” rating by Evercore on Thursday, August 3. The rating was upgraded by RBC Capital Markets on Friday, March 11 to “Outperform”. The firm has “Buy” rating by S&P Research given on Wednesday, August 12. Goldman Sachs reinitiated Symantec Corporation (NASDAQ:SYMC) on Monday, March 21 with “Neutral” rating. The firm earned “Buy” rating on Friday, April 6 by Standpoint Research. Wunderlich maintained Symantec Corporation (NASDAQ:SYMC) rating on Tuesday, August 11. Wunderlich has “Hold” rating and $25.0 target.

Analysts await Symantec Corporation (NASDAQ:SYMC) to report earnings on May, 9. They expect $0.25 earnings per share, up 400.00% or $0.20 from last year’s $0.05 per share. SYMC’s profit will be $155.39M for 27.80 P/E if the $0.25 EPS becomes a reality. After $0.38 actual earnings per share reported by Symantec Corporation for the previous quarter, Wall Street now forecasts -34.21% negative EPS growth.

Since March 5, 2018, it had 0 buys, and 3 sales for $2.63 million activity. 4,000 Symantec Corporation (NASDAQ:SYMC) shares with value of $110,880 were sold by Vautrinot Suzanne M. 41,284 shares were sold by TAYLOR SCOTT C, worth $1.14M. Rosch Francis C sold 51,899 shares worth $1.38M.

Investors sentiment increased to 0.92 in 2017 Q4. Its up 0.06, from 0.86 in 2017Q3. It is positive, as 56 investors sold SYMC shares while 144 reduced holdings. 45 funds opened positions while 139 raised stakes. 548.16 million shares or 4.09% less from 571.53 million shares in 2017Q3 were reported. Barry Inv Advisors Limited Liability Corporation holds 8,538 shares or 0.09% of its portfolio. Goodwin Daniel L reported 0.12% stake. Geode Cap Mngmt has 0.06% invested in Symantec Corporation (NASDAQ:SYMC). Employees Retirement System Of Texas holds 0.01% or 37,000 shares in its portfolio. Moreover, Washington Tru Bancorp has 0.01% invested in Symantec Corporation (NASDAQ:SYMC) for 2,300 shares. Acadian Asset Limited Liability has invested 0% of its portfolio in Symantec Corporation (NASDAQ:SYMC). The Pennsylvania-based Vantage Inv Advsr has invested 0% in Symantec Corporation (NASDAQ:SYMC). Ajo LP accumulated 28,158 shares or 0% of the stock. Swiss Savings Bank, Switzerland-based fund reported 2.27 million shares. Parametric has invested 0.06% of its portfolio in Symantec Corporation (NASDAQ:SYMC). 1,300 are held by Capital Advsr Ltd Liability Corporation. Petrus Lta holds 2.5% of its portfolio in Symantec Corporation (NASDAQ:SYMC) for 360,000 shares. Ameritas Inv Incorporated has 26,259 shares for 0.03% of their portfolio. Ing Groep Nv owns 20,163 shares. London Of Virginia accumulated 0.2% or 992,385 shares.

Symantec Corporation (NASDAQ:SYMC) Institutional Positions Chart